CD40LG and Alzheimer disease: In terms of anti-αSyn IgM, both AD and DLB patients demonstrated reduced levels compared to PD (AD: p = 0.007; DLB: p = 0.045) and controls (AD: p < 0.001; DLB: p < 0.001) (Fig. 2B; Table 3).